Avicanna is a biopharmaceutical company that focuses on the development of the medical cannabis space.
Avicanna has raised $429K in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2026.
Avicanna's investors include Canaccord Genuity Group, Sprott Inc., Splash Beverage Group, Beacon Securities, Paradigm Capital.
Avicanna is headquartered in Toronto, Canada.
Avicanna is a biopharmaceutical company that focuses on the development of the medical cannabis space.
Avicanna is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Avicanna — Funding & Investors." VCBacked, June 12, 2026, https://www.vcbacked.co/company/avicanna. Accessed November 12, 2026.
VCBacked. (2026). Avicanna — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/avicanna
{{cite web |title=Avicanna — Funding & Investors |url=https://www.vcbacked.co/company/avicanna |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Avicanna? Request a listing update